PopulationsHuman trial7,769 participantsCohort study

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Figure 1. Prevalence of preexisting hypertension in REPRIEVE (N = 7769).
Open the figure at full size
Figure 1. Prevalence of preexisting hypertension in REPRIEVE (N = 7769).Prevalence of preexisting hypertension in REPRIEVE (N = 7769).Hoffman et al.

Open Forum Infectious Diseases

The paper

University of California, Los Angeles · Harvard University

Open Forum Infectious Diseases · 20 Aug 2026

doi.org/10.1093/ofid/ofag507PubMed 42699213

More on Hypertension